申请人:Takeda Pharmaceutical Company Limited
公开号:US20150329556A1
公开(公告)日:2015-11-19
The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR
1
(R
1
is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R
2
is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH
2
), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
本发明提供了一种新型酰胺衍生物,具有基质金属蛋白酶抑制活性,并且作为药用剂是有用的,该化合物由以下式(I)表示,其中环A是一个可选择取代的含氮杂环,环B是一个可选择取代的单环同核环或可选择取代的单环杂环,Z是N或NR1(R1是氢原子或可选择取代的碳氢基团),是一个单键或双键,R2是氢原子或可选择取代的碳氢基团,X是一个具有1到6个原子的可选择取代的间隔物,环C是(1)一个可选择取代的同核环或(2)一个除了由(II)表示的环之外的可选择取代的杂环(X′是S、O、SO或CH2),并且环B和环C中至少有一个有取代基,但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]2-羟基丙基}5,6-二甲基-4-氧代-1,4-二氢噻唑并[2,3-d]嘧啶-2-羧酰胺,或其盐。